284 related articles for article (PubMed ID: 33671493)
1. Neurodevelopmental Outcomes and Gut Bifidobacteria in Term Infants Fed an Infant Formula Containing High sn-2 Palmitate: A Cluster Randomized Clinical Trial.
Wu W; Zhao A; Liu B; Ye WH; Su HW; Li J; Zhang YM
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671493
[TBL] [Abstract][Full Text] [Related]
2. Effect of high β-palmitate content in infant formula on the intestinal microbiota of term infants.
Yaron S; Shachar D; Abramas L; Riskin A; Bader D; Litmanovitz I; Bar-Yoseph F; Cohen T; Levi L; Lifshitz Y; Shamir R; Shaoul R
J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):376-81. PubMed ID: 23201699
[TBL] [Abstract][Full Text] [Related]
3. Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity.
Yao M; Lien EL; Capeding MR; Fitzgerald M; Ramanujam K; Yuhas R; Northington R; Lebumfacil J; Wang L; DeRusso PA
J Pediatr Gastroenterol Nutr; 2014 Oct; 59(4):440-8. PubMed ID: 24840511
[TBL] [Abstract][Full Text] [Related]
4. The influence of the position of palmitate in infant formula triacylglycerols on health outcomes.
Miles EA; Calder PC
Nutr Res; 2017 Aug; 44():1-8. PubMed ID: 28821313
[TBL] [Abstract][Full Text] [Related]
5. Effect of bovine milk fat-based infant formulae on microbiota, metabolites and stool parameters in healthy term infants in a randomized, crossover, placebo-controlled trial.
Looijesteijn E; Brouwer RWW; Schoemaker RJW; Ulfman LH; Ham SL; Jeurink P; Karaglani E; van IJcken WFJ; Manios Y
BMC Nutr; 2022 Aug; 8(1):93. PubMed ID: 36038938
[TBL] [Abstract][Full Text] [Related]
6. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial.
Nowacki J; Lee HC; Lien R; Cheng SW; Li ST; Yao M; Northington R; Jan I; Mutungi G
Nutr J; 2014 Nov; 13():105. PubMed ID: 25373935
[TBL] [Abstract][Full Text] [Related]
7. Effect of an infant formula containing sn-2 palmitate on fecal microbiota and metabolome profiles of healthy term infants: a randomized, double-blind, parallel, controlled study.
Guo D; Li F; Zhao J; Zhang H; Liu B; Pan J; Zhang W; Chen W; Xu Y; Jiang S; Zhai Q
Food Funct; 2022 Feb; 13(4):2003-2018. PubMed ID: 35098958
[TBL] [Abstract][Full Text] [Related]
8. Growth, stool consistency and bone mineral content in healthy term infants fed sn-2-palmitate-enriched starter infant formula: A randomized, double-blind, multicentre clinical trial.
Béghin L; Marchandise X; Lien E; Bricout M; Bernet JP; Lienhardt JF; Jeannerot F; Menet V; Requillart JC; Marx J; De Groot N; Jaeger J; Steenhout P; Turck D
Clin Nutr; 2019 Jun; 38(3):1023-1030. PubMed ID: 29903473
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome.
Bazanella M; Maier TV; Clavel T; Lagkouvardos I; Lucio M; Maldonado-Gòmez MX; Autran C; Walter J; Bode L; Schmitt-Kopplin P; Haller D
Am J Clin Nutr; 2017 Nov; 106(5):1274-1286. PubMed ID: 28877893
[No Abstract] [Full Text] [Related]
10. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial.
Holscher HD; Faust KL; Czerkies LA; Litov R; Ziegler EE; Lessin H; Hatch T; Sun S; Tappenden KA
JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):95S-105S. PubMed ID: 22237884
[TBL] [Abstract][Full Text] [Related]
11. Impact of an Infant Formula Containing a Novel Fat Blend (Cow's Milk Fat, Fish and Vegetable Oil) and Prebiotics on Stool Fatty Acid Soaps and Erythrocyte Fatty Acid Profiles in Full-Term Healthy Newborns.
Lambidou M; Alteheld B; Fimmers R; Jochum F; Nomayo A; Stehle P
Ann Nutr Metab; 2021; 77(3):138-145. PubMed ID: 33934094
[TBL] [Abstract][Full Text] [Related]
12. Early Gut Colonization With Lactobacilli and Staphylococcus in Infants: The Hygiene Hypothesis Extended.
Salminen S; Endo A; Isolauri E; Scalabrin D
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):80-6. PubMed ID: 26230902
[TBL] [Abstract][Full Text] [Related]
13. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
[TBL] [Abstract][Full Text] [Related]
14. Effect of formula composition on the development of infant gut microbiota.
Hascoët JM; Hubert C; Rochat F; Legagneur H; Gaga S; Emady-Azar S; Steenhout PG
J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):756-62. PubMed ID: 21593648
[TBL] [Abstract][Full Text] [Related]
15. Association of the Infant Gut Microbiome With Early Childhood Neurodevelopmental Outcomes: An Ancillary Study to the VDAART Randomized Clinical Trial.
Sordillo JE; Korrick S; Laranjo N; Carey V; Weinstock GM; Gold DR; O'Connor G; Sandel M; Bacharier LB; Beigelman A; Zeiger R; Litonjua AA; Weiss ST
JAMA Netw Open; 2019 Mar; 2(3):e190905. PubMed ID: 30901046
[TBL] [Abstract][Full Text] [Related]
16. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.
Estorninos E; Lawenko RB; Palestroque E; Sprenger N; Benyacoub J; Kortman GAM; Boekhorst J; Bettler J; Cercamondi CI; Berger B
Am J Clin Nutr; 2022 Jan; 115(1):142-153. PubMed ID: 34617558
[TBL] [Abstract][Full Text] [Related]
17. Early Effect of Supplemented Infant Formulae on Intestinal Biomarkers and Microbiota: A Randomized Clinical Trial.
Castanet M; Costalos C; Haiden N; Hascoet JM; Berger B; Sprenger N; Grathwohl D; Brüssow H; De Groot N; Steenhout P; Pecquet S; Benyacoub J; Picaud JC
Nutrients; 2020 May; 12(5):. PubMed ID: 32443684
[TBL] [Abstract][Full Text] [Related]
18. Infant formula with cow's milk fat and prebiotics affects intestinal flora, but not the incidence of infections during infancy in a double-blind randomized controlled trial.
Nomayo A; Schwiertz A; Rossi R; Timme K; Foster J; Zelenka R; Tvrdik J; Jochum F
Mol Cell Pediatr; 2020 Jul; 7(1):6. PubMed ID: 32613402
[TBL] [Abstract][Full Text] [Related]
19. Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants.
Vivatvakin B; Mahayosnond A; Theamboonlers A; Steenhout PG; Conus NJ
Asia Pac J Clin Nutr; 2010; 19(4):473-80. PubMed ID: 21147707
[TBL] [Abstract][Full Text] [Related]
20. A comparison of two probiotic strains of bifidobacteria in premature infants.
Underwood MA; Kalanetra KM; Bokulich NA; Lewis ZT; Mirmiran M; Tancredi DJ; Mills DA
J Pediatr; 2013 Dec; 163(6):1585-1591.e9. PubMed ID: 23993139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
